Letter to the Editor

Vol. 44 No. 6 (2018): Urology Research and Practice

Article Sidebar

Full Text PDF
Published: Jul 25, 2019
Keywords:
AVES Editorial Office

Main Article Content

Drisya Udayan
Department of Microbiology, Amrita Institute of Medical Sciences,Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
Sadia Khan
Department of Microbiology, Amrita Institute of Medical Sciences,Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
Unnimaya Pullanhi
Department of Microbiology, Amrita Institute of Medical Sciences,Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
Anil Kumar
Department of Microbiology, Amrita Institute of Medical Sciences,Amrita Vishwa Vidyapeetham, Kochi, Kerala, India

Fosfomycin as a promising alternative to treat urinary tract infection due to multidrug resistant uropathogens

Main Article Content

Drisya Udayan
Department of Microbiology, Amrita Institute of Medical Sciences,Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
Sadia Khan
Department of Microbiology, Amrita Institute of Medical Sciences,Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
Unnimaya Pullanhi
Department of Microbiology, Amrita Institute of Medical Sciences,Amrita Vishwa Vidyapeetham, Kochi, Kerala, India
Anil Kumar
Department of Microbiology, Amrita Institute of Medical Sciences,Amrita Vishwa Vidyapeetham, Kochi, Kerala, India

Abstract

Abstract


Cite this article as: Udayan D, Khan S, Pullanhi U, Kumar A. Fosfomycin as a promising alternative to treat urinary tract infection due to multidrug resistant uropathogens. Turk J Urol 2018; 44(6): 515.




Article Details